All Stories

  1. Rechallenge Therapy: New Dimensions in Cancer Therapy
  2. Synthesis, in-vivo, ADMET prediction, molecular docking studies, MD simulation, and DFT analysis of novel 1,3,4-oxadiazole-furan hybrids as anticonvulsants
  3. Copper-catalyzed synthesis of heterocycles via single and two-electron pathways
  4. Synthesis and Structure-Activity Relationship of Pyrazoline Derivatives for Antimicrobial Applications: Current Insights
  5. Zwitterion: Important Tool for the Regioselective Synthesis of Five‑Membered Heterocycles: Mechanistic and Synthetic Perspectives
  6. Synergistic Anti-dementia Effects of Symplocos racemosa Nanoemulsion: Isolation, Molecular Docking, and In Vivo Evaluation
  7. Advances in Synthesis of Piperazine Analogues and Molecular Targets: Unlocking Their Potential in CNS Disorder Therapy
  8. Advances in Chemotherapeutic Potential of Glycoconjugates against Cancer
  9. Recent Trends in the Synthesis of Benzimidazoles and Use of the Phillips Modification. A Review
  10. Utility of Palladium as a Catalyst for the Synthesis of Five and Six-Membered Heterocyclic Moieties
  11. Ludwig Knorr’s synthesis: Advances in heterocyclic synthesis of quinoline, quinolone, pyrazole, and pyrrole derivatives
  12. Targeting the NLRP3 inflammasome with natural products for ischemia–reperfusion injury across organs: mechanisms, structure–activity relationships, and delivery innovations
  13. Design, synthesis, in silico and in vivo evaluation of 1,3,4-oxadiazoles as anticonvulsant agents
  14. Unlocking the Potential of Polysaccharides for the Treatment of Lung Cancer
  15. Advances in Medicinal Chemistry of Fused and Substituted Piperazines: Unlocking their Potential as Anticancer Agents
  16. Hyperemesis Gravidarum: Causes, Symptoms, and Management
  17. Significant advances in catalytic strategies for the synthesis of trisubstituted imidazoles: a review
  18. Innovative Synthesis of 3,5-Disubstituted Pyrazoline with Heterocyclic System for Hybrid Development
  19. Integration of In-vivo screening, molecular docking, and molecular dynamics simulations for studying the antiepileptic potential of newly synthesized 5-naphthalen-1-yl-5,10-dihydro-1H-pyrimido[4,5-b]quinoline-2,4-diones in optimized reaction conditions...
  20. Fused and Substituted Piperazines as Anticancer Agents: A Review
  21. Synthesis, Pharmacological Activities, Structure-activity Relationship of 1,3,4-Oxadiazole-Piperazine Conjugates: A Review
  22. Quinoline and Analogs: Insight into the Synthesis, Biological Activity, Structure-Activity Relationship, and Interaction with Targets
  23. Hybrids of Benzimidazole-oxadiazole: A New Avenue for Synthesis, Pharmacological Activity and Recent Patents for the Development of More Effective Ligands
  24. Oxidative Coupling: An Important Tool for Pyrrole Synthesis
  25. The Catalysts-Based Synthetic Approaches to Quinolines: A Review
  26. Synthesis, in vitro, ADME Prediction, and Molecular Docking Studies of 1,3,4-Oxadiazole-piperazine Conjugates as New Anti-tubercular Agents
  27. Synthesis, in vivo, ADME, and molecular docking studies of 1,3,4-oxadiazole-pyridine conjugates as new anti-convulsant agents
  28. Pyrazoline and Analogs: Substrate-based Synthetic Strategies
  29. Quinoline-hydrazone Conjugates: Recent Insights into Synthetic Strategies, Structure-activity Relationship, and Biological Activities
  30. Synthesis, In Vivo, ADME Determination, and Molecular Docking Studies of 1,3,4‐Oxadiazoles Containing Pyridine and Piperazine Moieties as New Diuretic Agents
  31. Synthesis of Pyridines/Dihydropyridines via Hantzsch Reaction, Structure-activity Relationship and Interactions with Targets: A Review
  32. A review on innovative approaches in quinoline/isoquinoline synthesis: Unveiling the Pummerer reaction strategy
  33. Pharmacological Evaluation of Bioisosterically Replaced and TriazoleTethered Derivatives for Anticancer Therapy
  34. Hydrazides: An Important Tool for the Synthesis of 1,3,4-Oxadiazole
  35. Synthesis, in vitro, in silico, and molecular docking studies of some new benzothiazole-linked pyrazoline derivatives as orally administered beta-ketoacyl-ACP synthase III and malonyl-CoA inhibitors
  36. 1,3,4-Oxadiazoles as Anticancer Agents: A Review
  37. Recently Adopted Synthetic Protocols for Piperazines: A Review
  38. Synthesis, In vivo, and In silico Evaluation of New Pyrazoline‐Benzothiazole Conjugates as Antiepileptic Agents
  39. Hantzsch reaction: The important key for pyridine/dihydropyridine synthesis
  40. Recent Advances in Synthetic Strategies of Piperazine & its Analogs Via Rearrangement Reactions: A Review
  41. Insight into the Synthesis, Biological Activity, and Structure-activity Relationship of 1,2,4-Oxadiazole and Analogs: A Comprehensive Review
  42. Recent Innovations in Synthetic Methodologies and Patent Landscape of Quinoline Analogues: A Comprehensive Review
  43. Substrate‐based synthetic strategies and biological activities of 1,3,4‐oxadiazole: A review
  44. The medicinal chemistry of piperazines: A review
  45. Rearrangement reactions: Important tool for the synthesis of piperazines
  46. Synthetic Protocols, Structural Activity Relationship, and Biological Activity of Piperazine and its Derivatives
  47. Targeted Development of Pyrazoline Derivatives for Neurological Disorders: A Review
  48. Synthetic Strategies of Thiazolidine-2,4-dione Derivatives for the Development of New Anti-diabetic Agents: Compressive Review
  49. Synthesis, Characterization, in silico and in vivo Evaluation of Amino Acid Derived Schiff Bases of Quinoline-Benzimidazole Hybrids as Anti-epileptic Agents
  50. Protein kinase inhibitors in the management of cancer: therapeutic opportunities from natural compounds
  51. Synthetic Strategies of Pyrazoline Derivatives for the Development of New Anticancer Agents: Recent Updates
  52. Synthetic Protocols and Applications of 1,2,5-Oxadiazoles: A Review
  53. Recently Adopted Synthetic Approaches to Pyridine and Analogs: A Review
  54. Recent Updates on Synthesis, Biological Activity, and Structure-activity Relationship of 1,3,4-Oxadiazole-quinoline Hybrids: A Review
  55. An Exquisite Analysis on the Significance of Nutrient Supplementation in the Holistic Management of Poly-cystic Ovarian Syndrome
  56. Updates on the Synthetic Strategies and Structure-Activity Relationship of Anticonvulsant Benzothiazole and Benzimidazole Derivatives
  57. Synthesis and SAR of Potential Anti-Cancer Agents of Quinoline Analogues: A Review
  58. Significant Advancement in Various Synthetic Strategies and Pharmacotherapy of Piperine Derivatives: A Review
  59. Insights into adopted synthetic approaches for 1,2,4-oxadiazoles: A review
  60. Insights Into the Synthetic Strategies, Biological Activity, and Structure- Activity Relationship of Pyridine and Analogs: A Review
  61. Screening of Neuroprotective Action of Hydroethanolic Extract of Leaf of <i>Clematis buchananiana</i> in Diabetic-Induced Neuropathy
  62. An Updated Review Summarizing the Anticancer Efficacy of Melittin from Bee Venom in Several Models of Human Cancers
  63. 1,3,4-Oxadiazole and its Analogs: Recently Adopted Synthetic Approaches and Interaction with Targets
  64. Synthetic approaches and applications of an underprivileged 1,2,5‐oxadiazole moiety: A review
  65. A Review on Synthetic Strategies for Useful Oxadiazole Derivatives in Psychological Disorders
  66. Synthesis, Characterization, In Silico and In Vivo Evaluation of Benzimidazole‐Bearing Quinoline Schiff Bases as New Anticonvulsant Agents
  67. Recent Insights on Synthetic Methods and Pharmacological Potential in Relation with Structure of Benzothiazoles
  68. Synthesis of pyrazolines via 1,3-dipolar cycloaddition reactions
  69. Camphor and Menthol as Anticancer Agents: Synthesis, Structure-Activity Relationship and Interaction with Cancer Cell Lines
  70. Synthetic Approaches, Biological Activities, and Structure–Activity Relationship of Pyrazolines and Related Derivatives
  71. Current Developments in Synthetic Protocols for Pyrazolines and Analogs
  72. Synthesis Anticonvulsant and Cytotoxic Evaluation of Benzimidazole-Quinoline Hybrids Schiff Base Analogs
  73. Insight into the Synthesis, Biological Activity, and Structure-activity Relationship of Benzothiazole and Benzothiazole-hydrazone Derivatives: A Comprehensive Review
  74. Synthesis, Structure-Activity Relationship, and Biological Activity of Benzimidazole-Quinoline: A Review to Aid in the Design of a New Drug
  75. WITHDRAWN: Recent Advancement on Various Synthetic Strategies and Pharmacotherapy of Piperine and its Derivatives
  76. Synthesis, Anticonvulsant, and Molecular Docking Studies of (3,5-disubstituted-4,5-dihydro-1H-pyrazol-1-yl) (4-chlorophenyl) Methanone Derivatives
  77. Design, Synthesis, In Vivo, and In Silico Evaluation of Benzothiazoles Bearing a 1,3,4-Oxadiazole Moiety as New Antiepileptic Agents
  78. Molecular target interactions of quinoline derivatives as anticancer agents: A review
  79. A Comprehensive Review on Synthetic Approaches and Biological Activities of 1,3,4-oxadiazole
  80. Review on the discovery of new Benzimidazole derivatives as Anticancer Agents: Synthesis and Structure-Activity Relationship (2010-2022)
  81. Recent Advances in Synthetic Strategies of Benzimidazole and its Analogs: A Review
  82. Recent Updates on Synthetic Strategies and Biological Potential of 1,3,4- oxadiazole: Review
  83. Design, synthesis, in vivo and in silico evaluation of novel benzothiazole-hydrazone derivatives as new antiepileptic agents
  84. Synthetic Approach to Potential Anticancer Benzimidazole Derivatives: A Review
  85. Benzothiazole: Synthetic Strategies, Biological Potential, and Interactions with Targets
  86. Insights into Interactions of Human Cytochrome P450 17A1: A Review
  87. Pyridine Moiety: An Insight into Recent Advances in the Treatment of Cancer
  88. Anti-Diabetic Potentials of Thiazolidinedione Analogues with Efficient Synthetic Procedures: A Review of Literature
  89. Insight into the Isolation, Synthesis, and Structure-Activity Relationship of Piperine Derivatives for the Development of New Compounds: Recent Updates
  90. 1,3,4-Oxadiazoles as Potential Pharmacophore for Cytotoxic Potentiality: A Comprehensive Review
  91. Synthesis Characterization and Antibacterial Activity of Terazosin Hydrochloride Drug and Market Formulation
  92. Benzimidazole-Quinoline Hybrid Scaffold as Promising Pharmacological Agents: A Review
  93. Validated HPLC‐UV method for simultaneous quantification of phosphatidylinositol 3‐kinase inhibitors, copanlisib, duvelisib and idelalisib, in rat plasma: Application to a pharmacokinetic study in rats
  94. An Overview of Bioactive Alkaloid, Semi-Synthetic Analogs, Mechanism of Action and Structure-Activity Relationship of Piperine as Antioxidant
  95. Design, Synthesis and in vitro Antibacterial Evaluation of Naphthalen-2-yloxy based Oxadiazole-2-thione Derivatives
  96. Pyridine Moiety: Recent Advances in Cancer Treatment
  97. Recent Development in Nuclear Magnetic Resonance as a Technique for Quantitative Method Validation
  98. Synthesis and Anticancer Potentials of Quinoline Analogues: A Review of Literature
  99. Synthesis and Biological Potentials of Quinoline Analogues: A Review of Literature
  100. Synthesis, Characterization and Anticonvulsant Potential of 2,5-Disubstituted 1,3,4-Oxadiazole Analogues
  101. Onosma L.: A review of phytochemistry and ethnopharmacology